Upregulated Yap1 signature was also detected in patient-matched post-chemotherapy breast cancer tissues (Supplementary Fig. S15b, accession numbers GSE21974 and GSE4382), suggesting that Yap1 signaling activation is also an adaptive response to chemotherapies in breast cancers, similar to that in PDAC. This evidence concerns the gene YAP1 and breast carcinoma.